刚果红阳性纤维性肾小球肾炎:病例系列研究
该病例系列分析了18例刚果红阳性纤维性肾小球肾炎(congophilic fibrillary GN)的临床病理特征,并通过质谱法和DNAJB9免疫组化将其与刚果红阴性纤维性GN、淀粉样变性及健康个体比较。结果显示刚果红阳性纤维性GN缺乏淀粉样变性的蛋白质组学特征,而DNAJB9在所有纤维性GN中均可检测到,在淀粉样变性和健康个体中缺失。因此,不应仅依赖刚果红阳性来区分纤维性GN与肾淀粉样变性。
要点
- 刚果红阳性不能排除纤维性GN,需与淀粉样变性鉴别。
- DNAJB9是区分纤维性GN与淀粉样变性的可靠标志物。
- 刚果红阳性纤维性GN患者多数肾功能持续下降。
核心结论
- 刚果红阳性纤维性GN不应仅凭刚果红染色与肾淀粉样变性区分,质谱法和DNAJB9免疫组化有助于鉴别。
研究设计与样本
- 病例系列分析18例刚果红阳性纤维性GN,并与24例刚果红阴性纤维性GN、145例淀粉样变性及12例健康个体进行质谱法比较,部分病例行DNAJB9免疫组化。
主要发现
- 刚果红阳性纤维性GN病例中质谱法未检测到淀粉样变性蛋白质组学特征。
- DNAJB9在全部纤维性GN病例(无论刚果红阳性或阴性)中经质谱法检出,在淀粉样变性和健康个体中缺失;免疫组化证实了质谱结果。
- 18例刚果红阳性纤维性GN中,平均诊断年龄65岁,男性11例、女性7例;合并单克隆丙种球蛋白病35%、丙型肝炎病毒感染22%、恶性肿瘤17%、自身免疫病11%;无肾外淀粉样变性证据。
- 临床表现:蛋白尿100%、肾病综合征47%、血尿78%、慢性肾脏病83%;平均随访23个月,31%进展至终末期肾病,其余69%肾功能持续下降。
临床怎么用
- 对刚果红阳性的纤维性肾小球沉积物,应行质谱法和DNAJB9免疫组化以鉴别纤维性GN与淀粉样变性。
局限性
- 回顾性研究,未进行盲法病理评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Congo Red positivity with birefringence under polarized light has traditionally permitted classification of organized glomerular deposits as from amyloid or nonamyloid diseases. The absence of congophilia has been used to differentiate fibrillary glomerulonephritis (GN) from amyloidosis. We describe a series of fibrillary GN cases in which the deposits are Congo Red-positive (congophilic fibrillary GN) and discuss the role of DNAJB9 in distinguishing congophilic fibrillary GN from amyloidosis. STUDY DESIGN: Case series. SETTING & PARTICIPANTS: Analysis of the clinicopathologic characteristics of 18 cases of congophilic fibrillary GN. Mass spectrometry was performed and compared with 24 cases of Congo Red-negative fibrillary GN, 145 cases of amyloidosis, and 12 apparently healthy individuals. DNAJB9 immunohistochemistry was obtained for a subset of cases. RESULTS: The proteomic signature of amyloid was not detected using mass spectrometry among cases of congophilic fibrillary GN. DNAJB9, a recently discovered proteomic marker for fibrillary GN, was detected using mass spectrometry in all cases of fibrillary GN regardless of congophilia and was absent in cases of amyloidosis and in healthy individuals. DNAJB9 immunohistochemistry confirmed the mass spectrometry findings. The congophilic fibrillary GN cases included 11 men and 7 women with a mean age at diagnosis of 65 years. Concomitant monoclonal gammopathy, hepatitis C virus infection, malignancy, or autoimmune disease was present in 35%, 22%, 17%, and 11% of patients, respectively. No patient had evidence of extrarenal amyloidosis. Patients presented with proteinuria (100%), nephrotic syndrome (47%), hematuria (78%), and chronic kidney disease (83%). After a mean follow-up of 23 months, 31% of patients progressed to end-stage kidney disease and the remaining 69% had persistently reduced kidney function. LIMITATIONS: Retrospective nature. Blinded pathology evaluations were not performed. CONCLUSIONS: The congophilic properties of organized fibrillary deposits should not be solely relied on in differentiating fibrillary GN from renal amyloidosis. Mass spectrometry and DNAJB9 immunohistochemistry can be useful in making this distinction.
引用
- Alexander MP, Dasari S, Vrana JA, et al. Congophilic Fibrillary Glomerulonephritis: A Case Series. Am J Kidney Dis. 2018. PMID: 29866458. doi:10.1053/j.ajkd.2018.03.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。